The store will not work correctly when cookies are disabled.
Triethyl-(2,5,9-trimethyl-7-oxo-7H-furo[3,2-g]chromen-3-ylmethyl)-ammonium
ID: ALA539871
PubChem CID: 10595782
Max Phase: Preclinical
Molecular Formula: C21H28ClNO3
Molecular Weight: 342.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC[N+](CC)(CC)Cc1c(C)oc2c(C)c3oc(=O)cc(C)c3cc12.[Cl-]
Standard InChI: InChI=1S/C21H28NO3.ClH/c1-7-22(8-2,9-3)12-18-15(6)24-21-14(5)20-16(11-17(18)21)13(4)10-19(23)25-20;/h10-11H,7-9,12H2,1-6H3;1H/q+1;/p-1
Standard InChI Key: MMXITINVDYBCKZ-UHFFFAOYSA-M
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
7.0417 -4.5250 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.8500 -6.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -7.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4250 -6.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4625 -7.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8500 -7.3167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9500 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4625 -6.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4917 -6.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9792 -6.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9792 -7.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9417 -6.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5042 -7.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5000 -6.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6625 -5.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0542 -5.3250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0250 -7.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -8.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8917 -6.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9792 -5.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6417 -5.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4542 -5.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8667 -4.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2667 -4.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1250 -4.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0625 -5.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
4 2 1 0
5 8 2 0
6 9 1 0
7 3 2 0
8 12 1 0
9 2 2 0
10 8 1 0
11 5 1 0
12 4 2 0
13 14 1 0
14 10 2 0
15 2 1 0
16 15 1 0
17 13 2 0
18 7 1 0
19 9 1 0
20 10 1 0
21 16 1 0
22 16 1 0
23 16 1 0
24 23 1 0
25 22 1 0
26 21 1 0
6 3 1 0
7 5 1 0
11 13 1 0
M CHG 2 1 -1 16 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.46 | Molecular Weight (Monoisotopic): 342.2064 | AlogP: 4.84 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.35 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -0.20 | CX LogD: -0.20 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.49 | Np Likeness Score: 0.03 |
References
1. Wulff H, Rauer H, Düring T, Hanselmann C, Ruff K, Wrisch A, Grissmer S, Hänsel W.. (1998) Alkoxypsoralens, novel nonpeptide blockers of Shaker-type K+ channels: synthesis and photoreactivity., 41 (23): [PMID:9804693] [10.1021/jm981032o] |